| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |